JM and KBR sign global strategic alliance for ammonia-methanol coproduction process
Johnson Matthey (JM), a leader in sustainable technologies, and KBR, (Houston, USA) announced today that they have signed a global strategic alliance agreement to license a ground-breaking ammonia-methanol coproduction process that combines the company’s market leading ammonia and methanol process technologies.
Scintacor interview with Chief Technical Officer - Andrew Lee
Scintacor's Chief Technical Officer (CTO) Andrew Lee answers some pertinent questions...
Is sleep deprivation affecting your workforce?
One in four adults reported sleep problems during lockdown. With the threat of regional lockdowns still in place, your team could be at risk of sleep deprivation.
Cancer drug can rebalance kidney function in a devastating genetic disease
Researchers at the University of Cambridge and the University of Zurich have discovered that a drug newly approved for cancer improves kidney dysfunction in a mouse model of Dent disease 2 and Lowe syndrome.
The Cambridge Building Society Community Fund launches today with £500,000
The Cambridge Building Society has today launched a charitable fund with initial funding from the Society of £500,000. The Fund is available for local groups, charities and organisations who need financial support with their work to tackle home and housing needs.
Oxbridge office and lab space remained resilient against Covid-19
Take-up of office and laboratory space in the Oxford-Cambridge Arc has remained remarkably resilient in the first half of this year as the region’s leading role in the fight against Covid-19 continues to drive demand for space, according to recent reports by Property Consultants Bidwells.
Are you a scaleup or aspiring to scale?
Cambridge Network members with high growth plans are encouraged to complete the ScaleUp Institute’s 2020 Scaleup Survey - the UK’s largest survey of scaleup and growing companies.
Spark EV Technology selected to join world-first Net Zero programme
Cambridge-based Spark EV Technology has been selected to join Tech Nation’s Net Zero programme, designed to support 30 of the UK’s most promising scaleups that are contributing to the UK reaching its goal of net zero greenhouse gas emissions by 2050.
Achieving personalised therapeutics
The European Molecular Biology Laboratory (EMBL) is part of a growing movement to achieve cell-based medicine in Europe. This week hundreds of leading scientists, clinicians, industry leaders, and policymakers from around Europe declared this a new age for cell-based medicine by publishing a perspective piece, ‘Towards cell-based medicine in Europe’.
New website showcases Cambridge North plans
A digital platform showing plans for Cambridge North has been launched, along with a Twitter account for the development project.
Cambridge Intelligence launches KronoGraph: timeline visualizations that drive investigations
Cambridge Intelligence, creators of data visualization technologies that make the world safer, today announced KronoGraph: a new way to build scalable timeline visualizations.
EBCam Reward and Benefits Online - a free event for HR professionals
EBCam hosts a free interactive online event for HR and Finance professionals.
Fitness coach Joe Wicks is the inspiration behind Living Sport’s campaign to support vital work of #LocalJoes
Sports and physical activity charity, Living Sport, completed a #LocalJoes campaign to celebrate and support individuals who have kept people active and motivated during Covid-19.
Seed of an idea blossoms into a published novel
A story with a garden as the main character has finally blossomed into a published novel, years after its first draft was completed as part of a Creative Writing PhD.
Birketts announces its Class of 2020
Top 100 law firm, Birketts, has announced the appointment of 15 new trainee solicitors.
First look at new £105 million Henry Royce Institute Hub building
The Henry Royce Institute for advanced materials research and innovation celebrated a key milestone earlier this year ahead of the new national hub becoming fully operational in 2021.
CN Bio and Imperial College London collaborate to identify novel treatments for alcoholic hepatitis
CN Bio, a leading cell culture company that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, has announced a collaboration with Imperial College London, a world-class research university. The research will harness CN Bio’s Liver-on-Chip technology to advance the understanding of the underlying mechanisms of alcoholic…
Medovate announces distribution agreement with LTR Medical for sales of SAFIRA® in Australia and New Zealand
Medovate, the Cambridge based medical device development company, has concluded a distribution agreement with Brisbane-based LTR Medical which will provide exclusivity for SAFIRA® (SAFer Injection for Regional Anaesthesia) in Australia and New Zealand.
PragmatIC appoints Erik Langaker as Chair of the Board to support increasing scale of business
PragmatIC, a world leader in flexible electronics, has appointed Erik Langaker as independent Chair to complement its existing strong Board of Directors. This appointment comes alongside additional funding of over £13 million to support ongoing production ramp-up, accelerate manufacturing optimisation and drive continued product innovation.
Zero cables, zero touch...new ways of working
Check out 1plex's newly refurbished demo facility room - perfect for setting up meetings in this current environment.
PhoreMost and XtalPi sign AI-based pharmaceutical drug discovery collaboration agreement
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and XtalPi Inc., a leading algorithm-driven artificial intelligence (AI)-based pharmaceutical technology company, today announced they have entered into a drug discovery collaboration agreement. Financial details are not disclosed.
Cycle Pharmaceuticals secures $25 million debt financing
Cycle Pharmaceuticals, a privately-owned, global, patient-dedicated biotechnology company focused on developing and delivering medicines for rare diseases, announced that it has executed a definitive agreement for a $25 million credit facility with Deutsche Bank AG.
ThoughtRiver secures $10M funding to support global expansion as lawyers look to automate contracting and accelerate deal velocity
ThoughtRiver, the market leader in automated contract review and pre-screening, has today announced $10M (£7.5M) in Series A funding. The round is led by Octopus Ventures, a leading European venture capital firm which invests in technology innovation leaders.
Metrion Biosciences strengthens global business development team
Metrion Biosciences Limited, the specialist ion channel CRO and drug discovery company, today announced it has significantly enhanced its global business development capabilities, with additional resources now committed to support key regions in the USA, Europe and Japan.
Amazon continues to invest in Cambridge with a new team focused on Amazon Scout
Amazon today announced a new investment to expand research and development of autonomous delivery technology in the UK with the creation of a new team at its Cambridge development centre.